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Introduction
Many studies of infection prevention measures (ICM)
appear proving a reduction of methicillin-resistant Staphy-
lococcus aureus (MRSA) - colonisation or - infection
rates. Infection control personal has to decide if ICM
should be introduced in their hospital. Here we give an
example how an infection prevention potential (IPP) could
be calculated for MRSA patients in a 500-bed tertiary care
hospital under a given MRSA-screening, contact isolation
precaution and active surveillance program.
Objectives
To estimate an additional IPP using results of recently
published ICM, demonstrated by daily body washes with
chlorhexidine (CHX) for the reduction of blood stream
infections (BSI)(Climo MW et al. 2013), limited to
S. aureus infections.
Methods
MRSA screening policy included a general screening for
all medical wards and the intensive care unit; in all
other ward screening was performed as recommended
by the Robert-Koch-Institut. A culture based screening
(BD CHROMAgar MRSA II) was performed except
PCR-based (Roche LightCycler®Advanced) screening in
the intensive care unit. We reported results when
MRSA was suspected. Distinct subgroups of MRSA
patients were defined as I/II: colonisation on admission/
nosocomial acquired colonisation without infection dur-
ing hospital stay; III: nosocomial MRSA infection after
colonisation status at least 3 days before infection. IV:
nosocomial MRSA infection without prior colonisation,
V: infection already present on admission.
Results
In 2011 and 2012, I were 266/225, II: 19/30, III: 23/12, IV:
12/5. V: 25/18 patients, respectively. Preventable infections
were III with 23 per 332 and 12 per 285 MRSA cases in
2011 and 2012 respectively, yielding a prevention potential
of only 6,9% and 4,2% of all MRSA positive patients.
There were 17 primary and secondary BSIs. Calculating
with 8% reduction for S. aureus BSI by CHX body washes
reported by Climo they would prevent only one case in
our hospital within two years.
Conclusion
Before introduction of new ICM proposed by new stu-
dies MRSA patients could be subgrouped and an IPP
can be determined. Applying published reduction data
on the in-house IPP numbers gives a first estimate if the
new ICM could be a benefit.
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